Blockpass Brings KYC Solutions to Winners Network Web3 Rewards Platform
HONG KONG, Apr 11, 2022 – (ACN Newswire) – This week Blockpass is proud to…
HONG KONG, Apr 11, 2022 – (ACN Newswire) – This week Blockpass is proud to…
100% objective response rate and improvement in the rate of complete responses (CR) from 38%…
Los Angeles, California–(Newsfile Corp. – April 10, 2022) – The Sheeba team is pleased to…
Internet City, Dubai–(Newsfile Corp. – April 10, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – April 10, 2022) – LBank Exchange, a global digital asset…
FRAMINGHAM, Mass.–(BUSINESS WIRE)–#carbonreduction–Ameresco, Inc. (NYSE:AMRC), a leading cleantech integrator specializing in energy efficiency and renewable…
HAMILTON, Bermuda–(BUSINESS WIRE)–#RIMS2022–The Bermuda Business Development Agency (BDA) and its valued partners are ready to…
The four new decentralized tokens will give users price exposure, not ownership, to the underlying…
MIAMI, FL, Apr 9, 2022 – (ACN Newswire) – Cyber Yachts, the world’s first metaverse…
PHILADELPHIA, April 08, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the…
– Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and…
Victoria, British Columbia–(Newsfile Corp. – April 8, 2022) – On April 8, 2022, Andrew Wilkinson…
Menlo Park, CA / Hyderabad, IN, Apr 9, 2022 – (ACN Newswire) – TheCapitalNet TV…
ST. LOUIS–(BUSINESS WIRE)–McCarthy Holdings, Inc., one of the nation’s largest 100 percent employee-owned construction companies,…
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE:WFC) today issued the following statement responding to New…
LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”),…
– SL-9258 (TIGIT-Fc-LIGHT) combined with anti-PD(L)1 broadened anti-tumor activity of the checkpoint antibodies in aggressive…
Preclinical data demonstrated POC with robust in vitro and in vivo anti-tumor activity UCART20x22 allogeneic…
Three poster presentations highlight the unmet need for targeted therapies in BRAF and/or NRAS-altered cancers,…
Updated Data as of December 1, 2021 from Phase 1/2 study of IO102-IO103 in Combination…